Targeting the Mammalian Target of Rapamycin (mTOR) in Cancer Therapy: Lessons from Past and Future Perspectives

por Dufour, Marc, Dormond-Meuwly, Anne, Demartines, Nicolas, Dormond, Olivier
Publicado 2011

Targeting mTORC2 inhibits colon cancer cell proliferation in vitro and tumor formation in vivo

por Roulin, Didier, Cerantola, Yannick, Dormond-Meuwly, Anne, Demartines, Nicolas, Dormond, Olivier
Publicado 2010

Targeting renal cell carcinoma with NVP-BEZ235, a dual PI3K/mTOR inhibitor, in combination with sorafenib

por Roulin, Didier, Waselle, Laurent, Dormond-Meuwly, Anne, Dufour, Marc, Demartines, Nicolas, Dormond, Olivier
Publicado 2011

Antitumor activities of ATP-competitive inhibitors of mTOR in colon cancer cells

por Blaser, Benjamin, Waselle, Laurent, Dormond-Meuwly, Anne, Dufour, Marc, Roulin, Didier, Demartines, Nicolas, Dormond, Olivier
Publicado 2012